Müller O - Search Results

1

New indene-derivatives with anti-proliferative properties.

Karaguni IM, Glüsenkamp KH, Langerak A, Geisen C, Ullrich V, Winde G, Möröy T, Müller O. Karaguni IM, et al. Among authors: muller o. Bioorg Med Chem Lett. 2002 Feb 25;12(4):709-13. doi: 10.1016/s0960-894x(01)00839-3. Bioorg Med Chem Lett. 2002. PMID: 11844707

2

The new sulindac derivative IND 12 reverses Ras-induced cell transformation.

Karaguni IM, Herter P, Debruyne P, Chtarbova S, Kasprzynski A, Herbrand U, Ahmadian MR, Glüsenkamp KH, Winde G, Mareel M, Möröy T, Müller O. Karaguni IM, et al. Among authors: muller o. Cancer Res. 2002 Mar 15;62(6):1718-23. Cancer Res. 2002. PMID: 11912145

3

Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.

Müller O, Gourzoulidou E, Carpintero M, Karaguni IM, Langerak A, Herrmann C, Möröy T, Klein-Hitpass L, Waldmann H. Müller O, et al. Angew Chem Int Ed Engl. 2004 Jan 16;43(4):450-4. doi: 10.1002/anie.200352587. Angew Chem Int Ed Engl. 2004. PMID: 14735532 No abstract available.

4

Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.

Waldmann H, Karaguni IM, Carpintero M, Gourzoulidou E, Herrmann C, Brockmann C, Oschkinat H, Müller O. Waldmann H, et al. Among authors: muller o. Angew Chem Int Ed Engl. 2004 Jan 16;43(4):454-8. doi: 10.1002/anie.200353089. Angew Chem Int Ed Engl. 2004. PMID: 14735533 No abstract available.

5

SMAF-1 inhibits the APC/beta-catenin pathway and shows properties similar to those of the tumor suppressor protein APC.

Karaguni IM, Gourzoulidou E, Carpintero M, Langerak A, Klein-Hitpass L, Möröy T, Winde G, Waldmann H, Müller O. Karaguni IM, et al. Among authors: muller o. Chembiochem. 2004 Sep 6;5(9):1267-70. doi: 10.1002/cbic.200400078. Chembiochem. 2004. PMID: 15368578 No abstract available.

6

Sulindac sulfide inhibits Ras signaling.

Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, Möröy T, Müller O. Herrmann C, et al. Among authors: muller o. Oncogene. 1998 Oct 8;17(14):1769-76. doi: 10.1038/sj.onc.1202085. Oncogene. 1998. PMID: 9778042

7

Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.

Winde G, Schmid KW, Brandt B, Müller O, Osswald H. Winde G, et al. Among authors: muller o. Dis Colon Rectum. 1997 Oct;40(10):1156-68; discussion 1168-9. doi: 10.1007/BF02055161. Dis Colon Rectum. 1997. PMID: 9336110 Clinical Trial.

8

Novel target genes of the Wnt pathway and statistical insights into Wnt target promoter regulation.

Ziegler S, Röhrs S, Tickenbrock L, Möröy T, Klein-Hitpass L, Vetter IR, Müller O. Ziegler S, et al. Among authors: muller o. FEBS J. 2005 Apr;272(7):1600-15. doi: 10.1111/j.1742-4658.2005.04581.x. FEBS J. 2005. PMID: 15794748 Free article.

9

Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test.

Kutzner N, Hoffmann I, Linke C, Thienel T, Grzegorczyk M, Urfer W, Martin D, Winde G, Traska T, Hohlbach G, Müller KM, Kuhnen C, Müller O. Kutzner N, et al. Among authors: muller km, muller o. Cancer Lett. 2005 Nov 8;229(1):33-41. doi: 10.1016/j.canlet.2004.12.011. Epub 2005 Jan 18. Cancer Lett. 2005. PMID: 16157216 Clinical Trial.

10

DNA alterations in sporadic colorectal tumors do not correlate with tumor staging diagnosed by the TNM system.

Deuter R, Linz J, Pietsch S, Winde G, Hentsch S, Müller O. Deuter R, et al. Among authors: muller o. Cancer Lett. 1996 Dec 3;109(1-2):161-9. doi: 10.1016/s0304-3835(96)04441-2. Cancer Lett. 1996. PMID: 9020916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,482 results

Search Page